Orbis Allan Gray LtdOrbis Allan Gray Ltd

Institutional investor · Portfolio as of Q2 2025

SEC EDGAR SourceSEC Filings

Top Holdings78 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

QXO INC

96.3M$2.1B10.1%

FLEETCOR TECHNOLOGIES INC

3.9M$1.3B6.2%$309.14+5.79%
6 qtrssince 2024-Q1
Increased
64

ANTHEM INC

2.9M$1.1B5.4%$364.27+3.62%
26 qtrssince 2019-Q1
Increased
62

NEBIUS GROUP NV

17.7M$976.7M4.7%$29.67+74.71%
19 qtrssince 2020-Q4
Increased
66

SMURFIT WESTROCK PLC

18.4M$794M3.9%$44.73-7.23%
4 qtrssince 2024-Q3
Increased
90

ALNYLAM PHARMACEUTICALS INC

2.1M$691.8M3.4%$271.64+20.05%
5 qtrssince 2024-Q2
Increased
73
BTIBTI
ADR

BRITISH AMERICAN TOB-SP ADR

14.5M$686.5M3.3%$31.10+43.90%
26 qtrssince 2019-Q1
Increased
69

KINDER MORGAN INC

22.6M$665.5M3.2%$19.34+44.61%
16 qtrssince 2021-Q3
Increased
60

GXO LOGISTICS INC

13.2M$641.6M3.1%$58.55-16.31%
16 qtrssince 2021-Q3
Decreased
0
PDDPDD
ADR

PDD HOLDINGS INC

5.6M$591.1M2.9%$111.19-5.44%
3 qtrssince 2024-Q4
Increased
87
ITUBITUB
Preferred

ITAU UNIBANCO H-SPON PRF ADR

84.5M$574.1M2.8%$5.44+10.76%
2 qtrssince 2025-Q1
Increased
87

INTERACTIVE BROKERS GRO-CL A

9.7M$539.7M2.6%$41.00+31.27%
15 qtrssince 2021-Q4
Increased
87
SHELSHEL
ADR

SHELL PLC-ADR

7.3M$516.4M2.5%$52.16+28.87%
14 qtrssince 2022-Q1
Increased
61

STERIS PLC

2.1M$504.5M2.5%$225.64+5.29%
2 qtrssince 2025-Q1
Increased
70

RXO, Inc.

31.4M$493.2M2.4%$21.51-26.69%
11 qtrssince 2022-Q4
Increased
56
NTESNTES
ADR

NETEASE INC-ADR

3.5M$472M2.3%$85.45+53.94%
26 qtrssince 2019-Q1
Decreased
0

MICRON TECHNOLOGY INC

3.5M$426.2M2.1%$83.71+48.75%
13 qtrssince 2022-Q2
Increased
74

WALT DISNEY CO/THE

3.4M$415.6M2.0%$87.59+38.74%
8 qtrssince 2023-Q3
Decreased
0

XPO INC

3.2M$397.8M1.9%$34.53+269.20%
26 qtrssince 2019-Q1
Increased
57

UNITEDHEALTH GROUP INC

1.1M$339M1.6%$374.31-18.48%
26 qtrssince 2019-Q1
Increased
71
$20.6B
AUM
78
Positions
Q2 2025
Filing
Rating · 2.5
Quarterly Portfolio Change
+5%Q1'24$16.7B-4%Q2'24$16.1B+18%Q3'24$18.9B-2%Q4'24$18.6B-6%Q1'25$17.5B+18%Q2'25$20.6B
Activity profile
$ moved · Q2'25
New13%Increased48%Decreased23%Exited15%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.6 years
<1Q9%1-4Q19%1-2Y19%2Y+53%

Orbis Allan Gray Ltd manages $20.6B across 78 positions as of Q2 2025. Top holdings: QXO (10.1%), CPAY (6.2%), ELV (5.4%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2.5/5.0.

Q2 2025 Summary

Active quarter - 12 new positions, 12 exits, 40 increased. Top move: SW (INCREASED, conviction 90). Portfolio: $20.6B across 78 positions.

Top holdings by portfolio weight

Total AUM$21B
QXO10.09%
CPAY6.22%
ELV5.40%
NBIS4.75%
SW3.86%
ALNY3.36%
BTI3.34%
KMI3.24%
GXO3.12%
PDD2.87%
Other2.79%

Portfolio allocation by GICS sector

Sectors11
Industrials19.43%
Healthcare16.28%
Technology12.04%
Communication Services11.45%
Financial Services11.02%
Consumer Cyclical9.51%
Energy6.30%
Basic Materials5.92%
Consumer Defensive4.22%
Utilities1.41%
Other2.41%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Industrials, Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record64
Conviction48
Concentration60
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
FSVFSVFIRSTSERVICE CORP NEW
Q3 2024 Q2 2026+3.8M shares+$533.5M
8Q
MCSMCSMARCUS CORP DEL
Q3 2024 Q2 2026+1.4M shares+$42.6M
8Q
BURBURBURFORD CAPITAL LIMITED
Q3 2024 Q2 2026+8.4M shares-$21.1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used